Welcome to Twist Bioscience Fiscal 2021 Second Quarter Financial Results Conference Call. [Operator Instructions]
I would now like to turn the conference call over to Jim Thorburn, Chief Financial Officer.
Jim Thorburn --
Chief Financial Officer
Thank you, operator. Good afternoon, everyone. I'd like to thank all of you for joining us today for Twist Bioscience conference call to review our fiscal 2021 second quarter financial results and business progress. We did issue our financial results earlier this afternoon, which is available at our website at www.twistbioscience.com. With me on today's call is Dr. Emily Leproust, CEO and Co-Founder of Twist. Emily will begin with a review of our recent progress in Twist businesses. I will report on our financial and operational performance. And Emily will discuss our upcoming milestones and direction. We will then open the call for questions. As a reminder, this call is being recorded. The audio portion will be archived in the Investors section of our website and will be available for two weeks. During today's presentation, we will make forward-looking statements within the meaning of the U.S. federal securities laws. Forward-looking statements generally relate to the future events or future financial or operating performance.